Climb Bio, Inc.
CLYM
$1.21
-$0.02-1.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.19M | 15.41M | 12.39M | 9.42M | 8.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 98.70M | 78.68M | 70.83M | 67.21M | 16.82M |
| Operating Income | -98.70M | -78.68M | -70.83M | -67.21M | -16.82M |
| Income Before Tax | -92.98M | -73.90M | -69.12M | -64.20M | -14.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -92.98 | -73.90 | -69.12 | -64.20 | -14.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -92.98M | -73.90M | -69.12M | -64.20M | -14.53M |
| EBIT | -98.70M | -78.68M | -70.83M | -67.21M | -16.82M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -2.38 | -2.13 | -2.13 | -2.15 | -0.53 |
| Normalized Basic EPS | -1.47 | -1.31 | -1.31 | -1.35 | -0.32 |
| EPS Diluted | -2.38 | -2.13 | -2.13 | -2.15 | -0.53 |
| Normalized Diluted EPS | -1.47 | -1.31 | -1.31 | -1.35 | -0.32 |
| Average Basic Shares Outstanding | 229.56M | 189.74M | 152.54M | 112.60M | 109.09M |
| Average Diluted Shares Outstanding | 229.56M | 189.74M | 152.54M | 112.60M | 109.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |